Tag: FDA
GB Sciences Pursues FDA-Registered, First-in-Human Trial of Cannabis-based Therapy for Parkinson’s Disease
LAS VEGAS --. GB Sciences, Inc. (OTCQB: GBLX) is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather...
FDA Seeking Public Comments on Cannabis Rescheduling
Is the Trump administration softening its public stance on cannabis legalization? The U.S. Food and Drug Administration is asking for public input on whether...
HHS Secretary Azar Says ‘There is no Such Thing as Medical Marijuana’
At a press conference held in Kettering, Ohio, last Friday United States Department of Health and Human Services Secretary Alex Azar said, “There really...
CannaKids CEO Tracy Ryan Defends Use of Pediatric Medical Cannabis Against FDA Officials On...
Viewers Can Tune In On December 5, 2017, At 2:00 PM/CBS
Los Angeles, CA -On Tuesday December 5th , CannaKids CEO Tracy Ryan will make...
Pharmaceutical Company Develops Synthetic Cannabinoid Treatments
Pennsylvania-based Zynerba Pharmaceuticals is currently developing synthetic cannabinoid treatments, which were featured this week in the U.K.’s Daily Mail. Human trials are being conducted...
FDA Targets Companies Claiming Marijuana Can Treat Cancer
The FDA sent letters to four marijuana companies warning that they cannot claim their products are a treatment for cancer.
Although many patients have claimed...
Study Indicates THC, CBD Beneficial for Young Patients
Results of a study published this week in the medical journal Pediatrics said that cannabinoids could have potential benefits for children with seizures, as...
The FDA may Look Into Claims of Marijuana’s Health Benefits
The FDA Commissioner, Scott Gottlieb, implied the agency may start cracking down on companies claiming unsubstantiated benefits of medical marijuana.
Getting the FDA to admit...
